Interventional trials with anticoagulants in acutely ill medical patients: a methodological pitfall?
Open Access
- 16 June 2013
- journal article
- editorial
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 8 (6) , 461-464
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prophylaxis of venous thromboembolism in elderly patients with multimorbidityInternal and Emergency Medicine, 2013
- Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical PatientsNew England Journal of Medicine, 2013
- Prevention of VTE in Nonsurgical PatientsChest, 2012
- A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction ScoreJournal of Thrombosis and Haemostasis, 2010
- Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trialBMJ, 2006
- Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsCirculation, 2004
- A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical PatientsNew England Journal of Medicine, 1999
- Prevalence of Acute Pulmonary Embolism Among Patients in a General Hospital and at AutopsyChest, 1995
- Incidence of venous thromboembolism verified by necropsy over 30 years.BMJ, 1991
- Improving the sensitivity of the Barthel Index for stroke rehabilitationJournal of Clinical Epidemiology, 1989